Poland· PL-100121261
ACTI-trin
A pseudoephedrin, kombinationen product containing triprolidini hydrochloridum + pseudoephedrini hydrochloridum + dextromethorphani hydrobromidum, registered in Poland by Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.. The same ATC class is registered in 10 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Pseudoephedrin, kombinationen is registered in 10 of 19 countries.
Countries holding a registration under ATC R01BA52 (pseudoephedrin, kombinationen), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Pseudoephedrin, kombinationen · ATC R01BA52
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- United Statesprice
Price per daily dose
What a daily dose of pseudoephedrin, kombinationen costs, country by country.
Normalised to the WHO defined daily dose (0.24 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Pseudoephedrin, kombinationen · price per daily dose (0.24 g)
USD · FX 28 Sept 2026
- US United States$0.62 (acquisition cost)
The record
At a glance
URPL (Poland)- Active substance
- Triprolidini hydrochloridum + Pseudoephedrini hydrochloridum + Dextromethorphani hydrobromidum
- Manufacturer
- Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
- Country
- Poland (PL)
- ATC code
- R01BA52
- ATC class
- Pseudoephedrin, Kombinationen
- Defined daily dose
- 0.24 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991040819
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for pseudoephedrin, kombinationen.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pseudoephedrin, kombinationen · interactions on record
3 records
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Pseudoephedrin, kombinationen in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainCINFATOS DESCONGESTIVO SOLUCION ORALLaboratorios Cinfa S.A.
- United StatesHISTEX-DM New FormulationAllegis Pharmaceuticals, LLC
- IrelandBenylin Dual Action Dry Syrup, Pseudoephedrine 30mg, Dextromethorphan 10mg, Triprolidine 1.25mgJNTL Consumer Health I (Ireland) Limited
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Spain · Cinfatós Descongestivo
- United Kingdom (Northern Ireland) · Multi-Action Actifed Dry Coughs
- Ireland · Benylin Dual Action Dry
- Italy · Actifed Composto
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3ad918cc-d98a-4426-a1df-32db9a7caad8 GET /v1/drugs/3ad918cc-d98a-4426-a1df-32db9a7caad8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Syrop",
"source": "urpl",
"strength": "(1,25 mg + 30 mg + 10 mg)/5 ml",
"packaging": "05909991040819 ¦ OTC ¦ 48434\n1 butelka 100 ml",
"substance": "Tripirolidini hydrochloridum 1.25 mg/5 ml + Pseudoephedrini hydrochloridum 30 mg/5 ml + Dextromethorphani hydrobromidum 10 mg/5 ml",
"common_name": "Triprolidini hydrochloridum + Pseudoephedrini hydrochloridum + Dextromethorphani hydrobromidum",
"pl_product_id": "100121261",
"pozwolenie_nr": "10408",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about pseudoephedrin, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.